Gene Query: DYNC1H1

Dataset Description Geneva Score
Alteration of the microRNA network during the progression of Alzheimer’s disease 110.73
Efficient and quantitative high-throughput tRNA sequencing 105.46
Comparison of microRNA Profiling Platforms 53.13
Comparison of microRNA Profiling Platforms (HTS) 53.13
A radiolabeling-free, qPCR-based method for locus-specific pseudouridine detection 49.92
Comparative Transcriptomics of Triple Negative Breast Cancer Stem Cells and Differentiated Tumor Cells Identifies Teneurin-4 as a Potential Therapeutic Target 42.36
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer 39.66
RNA-seq profile of expanded human ST2-transduced Tregs cultured with IL-2 and TCR in the presence or absence of IL-33 39.61
Virus Mimicry in the Tumor Microenvironment Activates RIG-I Through Unshielding of Endogenous RNA in Exosomes [RNA-Seq] 38.25
Convergent exaptation of Alu and B/ID SINEs for Staufen-mediated mRNA decay 33.19
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 33.07
Ribo_seq (aka ribosome profiling) analysis of control and Myc-induced U2OS cells 27.76
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 27.48
An RNA-centric dissection of host complexes controlling flavivirus infection [RNA-Seq] 26.82
An RNA-centric dissection of host complexes controlling flavivirus infection 26.82
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 26.68
Genome wide miR-191 target profile determined by RIP and gene expression profiling 26.68
High-throughput sequencing of PROMPT-enriched samples. 25.83
Determination of tRNA aminoacylation levels by high throughput sequencing 24.26
Identification of microRNA-668 and microRNA-489 targets by RISC immunoprecipitation 23.16
Apoptotic endothelial cells release small extracellular vesicles loaded with immunostimulatory viral-like RNAs 22.25
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 22.22
CD97 is a Critical Regulator of Acute Myeloid Leukemia Stem Cell Function 21.89
IGF2BP3 controls cancer cell invasiveness by modulation RISC function 21.73
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein 21.57
Cancerous inhibitor of PP2A (CIP2A) Constrains Th17 Differentiation by Modulating STAT3 Signaling 21.39
Regulation of highly expressed hCINAP on translatome 21.34
Single-cell RNA-Seq Investigation of Foveal and Peripheral Expression in the Human Retina 21.27
Transcriptome analysis of A549 cells expressing a SUMOylation-deficient TRIM28 mutant in the context of influenza A virus infection 20.98
Radiomic and gEnomic approaches for the enhanced DIagnosis of REnal Cancer (REDIRECt): A translational pilot study 20.1
Whole transcriptome sequencing identifies increased CXCR2 expression in PNH granulocytes 19.48
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression 18.65
LINC00520 is Induced by Src, STAT3, and PI3K and Plays a Functional Role in Breast Cancer 18.63
Comparative total RNA and mRNA sequencing and systems analysis reveals nascent transcriptional response to early HIV-1 infection in a CD4+ T cell line 18.46
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 18.03
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages (RNA-Seq, CAGE and ChIP-Seq) 18.01
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages 18.01
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 18.01
Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer 17.43
Overexpression of ERG in cord blood progenitors promotes expansion and recapitulates molecular signatures of high ERG leukemias 17.05
Argonaute proteins couple chromatin silencing to alternative splicing 16.59
Argonaute proteins couple chromatin silencing to alternative splicing (RNA IP-Seq) 16.59
Transcriptome profiles of moderate dysplasia in oral mucosa associated with malignant conversion 16.56
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress 15.93
Genes regulated by soluble guanylyl cyclase in VCaP prostate cancer cells 15.8
Histone Demethylase-Assisted Somatic Cell Nuclear Transfer Facilitates Derivation of Human Pluripotent Stem Cells 15.16
Short and Long RNA sequencing of human mature erythrocytes 15.1
tRNA modification landscape selectively controls mitochondrial translation efficiency in MERRF 14.94
Role of microRNAs in the interaction between Salmonella and the host cell 14.71
Wide-spread disruption of transcription termination in HSV-1 infection: Next-generation sequencing of translational activityd by ribosome profiling 14.63
BET bromodomain proteins function as master transcription elongation factors independent of CDK9 recruitment [NET-seq] 14.2
Transcriptome data from human endocrine cells recovered from mouse grafts with pre-engraftment controls 14.07
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 14.0
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 13.99
mRNA Sequencing of Human PromoCells Using 3'-directed Digital Gene Expression (3'-DGE) Technique 13.96
Cooperation of GRSF1 and the mitochondrial degradosome (hSuv3-PNPase complex) in degradation of mitochondrial RNA 13.79
Cellular gene expression during Hepatitis C Virus replication revealed by Ribosome profiling 13.67
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 13.64
Improved LCL to iPSC reprogramming: RNA Analysis of LCLs, reprogrammed iPSCs, and differentiated NSCs reveal potential regulatory and functional processes involved in these cellular transitions. 13.35
The m 6 A-methylase complex recruits TREX and regulates mRNA export. 13.18
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 12.91
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 12.4
Definition of Natural Killer cell heterogeneity in humans and mice by high-throughput single-cell RNA sequencing 12.34
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 11.88
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] 11.72
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 11.3
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 11.07
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification 10.89
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification [Mouse and Human RNA-seq and BS-seq] 10.89
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 10.73
circRNA-sequencing 10.71
Quantitative comparison between cellular mRNAs and exosomal mRNAs in human iPSC-derived motor neurons 10.49
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 10.46
Transcriptome profile of HepG2-expressing ATP7B-H1069Q (liver hepatocellular cells) exposed to JNK or p38 Inhibitor 10.37
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) 10.08
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates 10.08
Exploring the RNA landscape of endothelial exosomes 9.89
Poly(ADP-ribosyl)ation dependent changes in CTCF-chromatin binding and gene expression in breast cells 9.88
ETS family proteins bind glucocorticoid receptor: relevance for treatment of Ewing sarcoma 9.85
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells 9.77
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells [RNA-seq] 9.77
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 9.64
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs [GRO-seq II] 9.51
Epigenomic landscape during organ formation in human early embryos 9.5
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 9.5
Single-cell ID-seq identifies BMP signaling as a driver of a late stage epidermal differentiation program. 9.47
Effect of BMP inhibition or stimulation of primary human keratinocytes 9.47
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells (Poly(I:C) and LPS) 9.43
Neutrophils in systemic onset Juvenile Idiopathic Arthritis display sepsis-like features which can be reverted by IL-1 blockade 9.39
RNA-Seq profiling in PBMCs and spinal cord from ALS patients and healthy controls 9.3
Comprehensive RNA-Seq profiling in PBMCs of ALS patients and healthy controls 9.3
Single cell RNA sequencing reveals microglia-like cells in cerebrospinal fluid  during virologically suppressed HIV 9.25
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 9.24
RNA sequencing of primary human platelets and in vitro cell lines 9.21
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 9.21
MYC dependent mRNA translation shapes gene expression and cell biology 9.12
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development [BM low-input mRNA-seq] 8.92
The mRNA expression analysis of psoriasis skin lesion mesenchymal stem cell 8.89
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 8.85
Transcriptomic analysis of primary human T cells and murine RAW 264.7 macrophages 3D cultured in different collagen densities 8.81
ONECUT2 Drives Neuroendocrine Prostate Cancer Through Hypoxia Signaling 8.78
Postnatal lipids drive hepatocyte maturation 8.72
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 8.68
The myelin protein PMP2 is regulated by SOX10 and drives melanoma cell invasion 8.67
Gene expression changes in THP1 cells at day 2 and 4 following shRNA knock-down of RUVBL2 8.67
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 8.46
Wide-scale analysis of alternative polyadenylation (APA) associated with proliferation and transformation using 3'-Seq 8.38
Identification of metabolically distinct adipocyte progenitor cells in human adipose tissues 8.3
Genes significantly down or Up-regulated upon RNF219 knockdown 8.28
Genome-wide detection of DNase I hypersensitive sites in single cells and FFPE tissue samples 8.27
Pain-driven transcriptome changes in synovium of knee osteoarthritis patients 8.22
Targeting JNK Pathway Expands Human Hematopoietic Stem Cells 8.19
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 8.19
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 8.18
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 8.18
Characterization of the Merkel cell carcinoma miRNome 8.16
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 8.03
Genetic disarray follows mutant KLF1-E325K expression in a congenital dyserythropoietic anemia patient 8.03
LINE-2 transposable elements are a source of functional human microRNAs and target sites 8.03
The transcriptome and chromatin accessbility landscape of mammalian germline 7.92
RNA-sequencing with micro-dissected boundary organoid into anterior, posterior, and boundary regions 7.79
Transcriptome profile of ATP7B KO cells and WT cells treated with Copper (Cu) to study Autophagy as a pro-survival mechanism in Wilson disease 7.75
Sequencing of freshly produced RNA following exposure of cells to DNA damage-inducing UV mimetic 4-hydroxyaminoquinolone (4-NQO) 7.7
RNA-sequencing experiment: Treatment of MCF-7 breast cancer cells with the novel small molecule ZNA 7.63
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 2: scRNA-seq) 7.52
Identification of transcription start sites for human A549 cell line using ReCappable-seq 7.46
Expression data for KDM1B knockdown in Glioma-Initiating Cells (GICs) 7.39
A systematic analysis of nuclear heat-shock protein 90 identifies a metazoan-specific regulatory module 7.24
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 7.23
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 7.21
RNA m5C Methylation in breast cancer using MeRIP-Seq 7.17
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export 7.12
Landscape and variation of RNA secondary structure across the human transcriptome 7.04
Identifying markers predicting successful graft outcome for clinical translation of hESC-based cell therapy for Parkinson’s disease 7.01
EZH2 inhibitor-mediated transcriptional profiling in prostate cancer cells [RNA-seq] 6.95
Distinct changes in transcriptional profiles and epigenetic patterns mediated by EZH2 inhibitors in sensitive and insensitive prostate cancer cells 6.95
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells [GRO-seq] 6.94
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells 6.94
Systematic discovery of endogenous human ribonucleoprotein complexes 6.87
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 6.82
ENPP1 Mutation Causes Recessive Cole Disease by Altering Melanogenesis 6.8
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 6.79
UBL5 is essential for pre-mRNA splicing and sister chromatid cohesion in human cells 6.71
Integrating single-cell transcriptomic data across different conditions, technologies, and species 6.65
RNA-seq analysis of melanoma and carcinoma cells expressing FOXQ1 6.57
RNA transcriptome analysis during HSV-1 infection 6.55
Genome-wide expression profiling of B Lymphocytes reveals IL4R increase in allergic asthma 6.46
Integration of kinase and calcium signaling at the level of chromatin underlines inducible gene activation in T cells 6.45
RNAseq to determine gene expression changes following depletion of SETDB1 in THP-1 AML Cells 6.35
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 6.34
Expression profiling of MCF-7 cells with treatment of TCDD 6.31
Expression profiling of MCF-7 cells with 10nM treatment of TCDD 6.31
A next generation sequencing based approach to identify extracellular vesicle mediated mRNA transfers between cells 6.29
Identification of miRNA signatures during the differentiation of hESCs into retinal pigment epithelial cells 6.28
MEIS1 regulates hematopoiesis in hPSCs 6.28
METTL3 and WTAP 6.22
Human cells contain natural double-stranded RNAs with potential regulatory capacity 6.1
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation 6.01
Genome-wide MAF1-dependent regulation of RNA polymerase III transcription 6.01
Genome-wide MAF1-dependent regulation of RNA polymerase III transcription [RNA-Seq] 6.01
Plasma cell mitochondrial pyruvate import controls the duration of humoral immunity. 6.0
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 5.99
oxLDL exposed trained monocytes 5.96
Transcriptomes of oxLDL exposed trained monocytes 5.96
Epigenetic programming during monocyte to macrophage differentiation and trained innate immunity 5.9
Recruiting Endogenous ADARs with Antisense Oligonucleotides to Reprogram the Transcriptome 5.9
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 5.88
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 5.88
CD95/Fas ligand mRNA is toxic to cells 5.85
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 5.84
Active translatome profiling with RiboLace in MCF7 cells 5.82
Expansion of adult human pancreatic tissue yields organoids harbouring progenitor cells with endocrine differentiation potential 5.81
mRNA expression profile of Lymphocytes by high-throuput sequencing 5.76
Gene expression profile of HGC27 gastric cancer cell p53 KO and KD 5.76
3’ Uridylation Expands miRNA Target Repertoire 5.69
Transcriptomic Dynamics during Differentiation Process of Human Pluripotent Cells into Hepatocyte-like Cells 5.69
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 5.64
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation 5.63
Integrating the Epigenome to Identify Novel Drivers of Hepatocellular Carcinoma 5.55
Anti-inflammatory effect of indoleacrylic acid (IA) 5.5
Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons 5.48
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HET] 5.41
DHX36 is the missing link to understand RNA G-quadruplex structures, mRNA stability, and translation [RNA-seq] 5.37
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer [RNA-Seq] 5.37
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer 5.37
Insights into snoRNA biogenesis and processing from PAR-CLIP of snoRNA core proteins and small RNA sequencing 5.35
RNA polymerase in pre-B-ALL cell lines 5.34
RNA-Seq analysis of human Tr1, Tregs and IL10neg cells 5.3
RNA-sequencing of human mammary epithelial cells (HMLEs) engineered to express either ER or ER-SOX4 with and without 4-OHT to induce nuclear translocation 5.3
Effects of human adipose tissue-derived and umbilical cord tissue-derived mesenchymal stem cells in a dextran sulfate sodium-induced mouse model 5.23
scRNASeq analysis of cycling cardiomyocytes 5.2
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 5.19
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (scRNA-Seq) 5.16
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 KO] 5.14
Widespread backtracking by RNA pol II is a major effector of gene activation, 5’ pause release, termination and transcription elongation rate 5.13
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 5.12
RNAseq analysis of the human neutrophil transcriptome, with and without in vitro cytokine stimulation 5.12
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation 5.11
Potent antitumor activity of Cabozantinib, a c-MET and VEGFR2 Inhibitor, in a Colorectal Cancer Patient-derived Tumor Explant Model 5.07
RNA-Seq from human ILC transitional populations 5.07
Expression profiling of ILC transitional populations and Aiolos accessability and H3K27ac histone modifications in transfected MNK3 cells 5.07
Gene expression profiles of rescue with wild type or SUMO double mutant TRIM24 5.05
HEK293 Heat-shock experiment 5.04
A cell-permeable stapled peptide inhibitor of the estrogen receptor/coactivator interaction 5.01
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 5.0
Unique features and clinical importance of acute alloreactive immune responses 4.97
Transcriptomic changes mediated by β-amyloid in human aortic endothelial cells (HAOEC) 4.91
Genome-wide view of the impact of Spt5-Pol II inhibitors (SPIs) on mRNA levels [RNA-Seq 24h] 4.83
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 4.8
lncRNA expression analysis in patients with eosinophilic and neutrophilic asthma 4.8
Rorc disruption in human FG pancreatic cancer cells 4.75
Synergy from Gene Expression and Network Mining (SynGeNet) method predicts genotype-specific synergistic drug combinations in melanoma 4.7
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with pancreatic carcinoma 4.69
Allogeneic mature human dendritic cells generate superior alloreactive regulatory T cells in the presence of IL-15 4.67
Profiling in vivo Bone Lesion (IVBL) and Orthotopic tumors by Next Generation Sequencing 4.65
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 4.63
Transcriptional profile of human STAT1-/- fibroblasts expressing LY6E or empty control vector 4.55
Single-cell transcriptomic analysis of tissue resident memory T cells in human lung cancer [ 10x genomics] 4.54
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 4.44
Global response to chemotherapy-induced apoptosis 4.42
Tracing the first hematopoietic stem cell generation in human embryo by single-cell RNA sequencing 4.41
Distinct roles of cohesin-SA1 and cohesin-SA2 in 3D chromosome organization  4.39
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 4.38
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 4.36
Zika virus antagonizes interferon response in patients and disrupts RIG-I-MAVS interaction through its CARD-TM domains 4.28
Gene expression signatures of innate lymphoid cells from human blood 4.28
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 4.2
Activation of a SOX2-dependent transcriptional regulatory circuit drives glioblastoma. 4.2
Genes encoding cognate receptors for IRI-related recipient cytokines are expressed in donor livers 4.2
RNA-seq analyses of human prostate cancer cells 4.18
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 4.17
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 4.17
Characterization of sperm lncRNA and its differently expression in the sperm of asthenozoospermic patients 4.16
Comparative transcriptome analysis reveals that ECM-Receptor Interaction contributes to the venous metastases of hepatocellular carcinoma 4.13
Antioxidant metabolism in activated CD8+ T cells regulates stem-like human memory T cell formation and anti-tumor immunity 4.1
Next Generation Sequencing of isolated EGFR+ and HLA-G+ first trimester human trophoblasts 4.09
Transcriptomics analysis of enteroendocrine cells following vertical sleeve gastrectomy 4.09
Transcriptomics analysis of human jejunal enteroendocrine cells after vertical sleeve gastrectomy 4.09
RNA deep sequencing analysis of glioma stem cells(GSCs) and non-GSCs 4.06
Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival 4.06
Gene expression profile of multiple myeloma cell lines treated with CB-5083 4.0
Genome-wide RNA deep sequencing of CAL-101 or AKTi primed human T cells in comparison to traditionally expanded T cells 3.99
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (human 3' mRNA-seq) 3.98
Identification of atheroprone shear stress responsive regulatory elements in endothelial cells 3.97
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation (RNA-Seq) 3.96
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation 3.96
A novel compound that blocks HIV-1 replication inhibits the splicing regulatory function of SRSF10 3.95
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion 3.93
A single-cell transcriptome atlas of the human pancreas 3.93
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells [RNA-seq] 3.93
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells 3.93
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 3.9
Transcriptome analysis of Jurkat T-ALL clones from control and CBAP-knockdown/knockout sets 3.85
TT-Seq captures the human transient transcriptome 3.83
Comprehensive comparative analysis of 5’ end RNA sequencing methods 3.8
miR-93 Targets in Human Endothelial Cells 3.78
Comparison of small cell lung cancer PDX model FHSC04 for response to LSD1 inhibitor RG6016/ORY1001 3.78
IL-6/Stat3-Dependent Induction of Distinct, Obesity-Associated Natural Killer Cells Deteriorates Energy and Glucose Homeostasis 3.75
The transcription and translation landscapes during human cytomegalovirus infection reveal novel host-pathogen interactions 3.75
DHX15 regulates CMTR1-dependent gene expression and cell proliferation 3.74
Widespread regulated alternative splicing of single codons accelerates proteome evolution 3.72
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 3.72
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 3.72
RNA-seq data for non-targeting siRNA and CDK11 siRNA transfection in SHhES8 cells 3.71
Whole blood RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 3.71
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells [RNA-Seq] 3.67
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells 3.67
Improved genome-wide mapping of uncapped and cleaved transcripts in eukaryotes—GMUCT 2.0 3.65
Club cells surviving influenza A virus infection induce temporary non-specific anti-viral immunity 3.58
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile [mRNA-Seq] 3.56
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile 3.56
Profiling premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis 3.54
Long non-coding RNA expression profile associated with malignant progression of oral submucous fibrosis 3.5
RNA-Seq following PCR-based sorting reveals rare cell transcriptional signatures 3.47
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 3.47
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 [RNA-Seq] 3.47
Comparative Analysis of the Transcriptome of Latent Autoimmune Diabetes (LADA) Patients from Eastern China 3.45
Transcriptome analysis of peripheral blood monocytes 3.44
Gene-Centric Functional Dissection of Human Genetic Variation Uncovers Regulators of Hematopoiesis 3.44
High-throughput RNA sequencing on circular RNA profiles of human bladder cancer tissues and normal bladder tissues 3.39
RNA-seq of naive and primed ES cells 3.38
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [mutant MEF2C] 3.37
Transcriptome landscape of human primary monocytes response upon different ligand glucocorticoids 3.35
RNA-sequencing of highly pure synovial tissue macrophages reveals two distinct osteoarthritis subgroups that indicate different disease mechanisms. 3.32
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 3.31
Unbiased evaluation of cell-free amniotic fluid transcriptome of term and preterm infants to detect fetal maturity 3.28
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 3.26
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 3.24
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 3.24
Radiation enhances melanoma response to immunotherapeutic and synergizes with benzodiazepines to promote improved anti-tumor activity 3.23
Small molecule-mediated reprogramming of human hepatocytes into bipotent progenitor cells 3.22
Defective structural RNA processing in relapsing-remitting multiple sclerosis 3.16
RNA-sequencing study of peripheral blood monocytes for chronic periodontitis 3.13
Expression analysis of primary human monocytes stimulated with an anti-TLR10 mAb (5C2C5) 3.09
SMYD2 specificly regulate BIX-01294 induced TP53 target genes revealed by RNA-Seq 3.08
TFPa/HADHA is required for fatty acid beta-oxidation and cardiolipin re-modeling in human cardiomyocytes 3.05
Simultaneous profiling of sexually transmitted bacterial pathogens, microbiome, and concordant host response in cervical samples using whole transcriptome sequencing analysis 3.01
Dermal endothelial cells of type 2 diabetic patients 2.95
Enhancement of Human B Cell Differentiation and Function in Lymph Nodes by the TLR9 Agonist MGN1703 2.94
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 2.9
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 2.9
H1609088 Human RNA-Sequencing 2.87
Short-term effect of Boost versus Radical doses of Intraoperative electron Radiotherapy in breast cancer tumor bed using high-throughput approaches 2.84
Transcriptome-wide analysis of IL2RA enhancer activation by CRISPRa 2.82
Differences in miRNA Detection Levels are Technology and Sequence Dependent [NGS] 2.82
Differences in miRNA Detection Levels are Technology and Sequence Dependent 2.82
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 2.78
Single-Cell Genotyping of Transcriptomes 2.77
RNA-seq of Single-Cell Genotyping of Transcriptomes 2.77
An optimization system for isolating and sequencing of single human colon cancer cells 2.76
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 2.74
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 2.71
Human serum and heparin-free platelet lysate as appropriate xeno-free alternatives for production of human MuStem cell batches 2.7
Transcriptomic profile of intestinal epithelial cells obtained from ileal endoscopic biopsies from newly-diagnosed, pediatric Crohn's disease patients and healthy controls. 2.68
Mutant KRAS/BRAF Reprograms the Enhancer Landscape via GATA1 to Drive Chemoresistance 2.67
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 2.65
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers [RNA-Seq] 2.63
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers 2.63
RNA sequencing of Formalin-Fixed, Paraffin-Embedded Specimens for Gene Expression Quantification and Data Mining 2.63
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 2.59
RNA-sequencing of Wnt-dependent and Wnt-independent of Glioblastoma stem cell cultures 2.55
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 2.54
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 2.47
Gene Expression Profile of human hepatocellular carcinoma by RNA sequencing 2.45
Large-scale profiling of intracellular signalling pathway activation reveals major distinctions between airway smooth muscle cells of asthmatics and non-asthmatics. 2.44
Gene expression changes after LOC550643 silencing 2.38
ADAR1-editing of cellular and measles virus-derived duplex RNA 2.36
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 2.36
Gene expression profile in endometrial organoids cultured in normal follicular phase vs PCOS-like hormone profile 2.32
Human Treg NaCl stimulation 2.31
Landscapes of gene translation in hepatocellular carcinoma tumors revealed by ribosome profiling 2.29
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 2.28
Influenza Vaccination Primes Human Myeloid Cell Cytokine Secretion and Natural Killer Cell Function 2.26
Identifying transcripts that are transcriptinoally regulated by CBFB and RUNX1 using RNAseq 2.25
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation 2.24
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation [RNA_Chondroblastoma_H3K36M_H3WT] 2.24
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress [human] 2.24
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress 2.24
An interaction with Ewing's sarcoma breakpoint protein EWS defines the specific oncogenic mechanism of ETS factors rearranged in prostate cancer 2.08
Transcriptome profiling of Cryptosporidium parvum infected lung and intestinal organoids 2.04
Functional separation of IL7Rα/KLRG1-defined CD8+ T cell populations in humans 2.03
RNA sequencing, chromatin accesibility and ChIP seq analysis of BAP1 -/- human liver organoids 2.03
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis 2.01
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis [Quant-Seq] 2.01
Recapitulating and Deciphering Tumor-stroma Microenvironment by Using a “LEGO” like 3D printed microfluidic device 2.0
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 1.97
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 1.96
Non-coding and coding transcriptional profiles are significantly altered in pediatric Retinoblastoma tumors 1.95
RNA-Seq in neutrophils from Antiphospholipid Syndrome 1.93
Codon usage optimization in pluripotent embryonic stem cells [tRNA sequencing] 1.89
A stably self-renewing adult blood-derived induced neural stem cell exhibiting patternability and epigenetic rejuvenation 1.89
Tpl-2 small molecule project 1.88
Tpl-2 and MEK small molecule inhibitors 1.88
Comprehensive Transcriptome Analysis of Cerebral Cavernous Malformation Across Multiple Species and Genotypes 1.86
Ex vivo Dynamics of Human Glioblastoma Cells in a Microvasculature-on-a-Chip System Correlates with Tumor Heterogeneity and Subtypes 1.84
RNA sequencing of 13 T-cell acute lymphoblastic leukemia patients (5 TCRAD-MYC translocated T-ALL_8TAL1-LMO2 T-ALL) 1.82
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 1.8
Impact on erythroid progenitor type on erythroid differntiation 1.79
HEXIM1 is induced by DHODH inhibition to suppress melanoma [Gro-Seq] 1.78
HEXIM1 is induced by DHODH inhibition to suppress melanoma 1.78
Characterizing smoking-induced transcriptional heterogeneity in the human bronchial epithelium at single-cell resolution 1.77
Effect of PBK knockdown on C4-2 cell transcriptome 1.74
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 1.74
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies 1.69
Molecular Pathology of adverse local tissue reaction caused by metal-on-metal implants 1.68
Transcriptional changes during naturally-acquired ZIKA Virus infection render dendritic cells highly conducive to viral replication 1.66
Primate-specific gene TMEM14B promotes cortical expansion and folding 1.66
RNA-sequencing of milk cells extracted from pre-partum secretions and longitudinally from mature human milk across the first year of lactation 1.65
Muscle transcriptome analysis following Total Knee Arthroplasty with Tourniquet 1.61
Hepatic transcriptome of pediatric hepatoblastoma. 1.61
Physiologic expression of Sf3b1K700E causes impaired erythropoieses, aberrant splicing, and sensitivity to pharmacologic spliceosome modulation 1.61
Transcriptomes in healthy and CHB fetal hearts 1.59
Mapping interactions for the TNIP2 hub protein 1.58
Whole-Transcriptome Profiling of Canine and Human in Vitro Models Exposed to a G-Quadruplex Binding Small Molecule 1.55
Molecular Criteria for Defining the Naive Human Pluripotent State 1.51
Recovery and analysis of nascent RNA 1.51
The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains 1.51
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 1.5
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 1.49
Next generation sequencing identifies discrete classes of box C/D snoRNAs featuring different ends and RNA binding protein dependency 1.49
Gene expression analysis of human adenomas. 1.48
Comparative Analysis of Cas9 Activators Across Multiple Species 1.47
Integrated high-throughput screen to identify novel treatment leads for pediatric acute myeloid leukemia (AML) 1.43
Cutaneous Immunoprofile of Three Spotted Fever Group Rickettsiosis 1.43
Expression analysis of THP1 cells following shRNA knock-down of RUVBL2 1.43
RNA sequencing of CACO-2 cells incubated with Bifidobacteria breve grown on human milk oligosaccharides. 1.42
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program 1.42
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program (RNA-Seq) 1.42
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 1.42
Neutrophils RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 1.4
Effect of ILF3 on translation during homeostasis and the antiviral response 1.39
Alagille_Nodder 1.38
RNA Seq of Alagille liver biopsies 1.38
nELAVL HITS-CLIP in Alzheimer's Disease patients 1.37
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 1.34
Evaluation of the effectiveness of semen collection and sperm purification methods for spermatozoa transcript profiling 1.34
Human Treg IL-12 stimulation 1.33
Human Tfh cell RNA bulk sequencing 1.31
Next generation sequencing of small RNAs isolated from exosomes in human semen 1.31
Hepatocyte maturation 1.27
A novel Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia [RNA-Seq II] 1.23
m6A-RNA mapping, SND1-RNA binding profile mapping and SND1-depletion in KSHV-infected B-lymphocytes 1.2
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with colorectal carcinoma 1.2
Transcriptomic analysis of inter- and intra-patient variation in human iPSC cardiomyocytes: Platform for precision medicine to predict drug toxicity 1.18
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 1.18
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs 1.16
A comprehensive gene expression analysis identifies novel immune signatures in cesarean-born infants 1.13
Functional TRIM24 degraders via conjugation of ineffectual bromodomain and VHL ligands [RNA-seq] 1.13
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis 1.12
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis [RNA-Seq_Hs] 1.12
RNA-seq analysis in Cornea epithelial cells (CECs), skin epithelial cells (SECs), LSCs after knocking down PAX6 (3-D shPAX6 LSCs) and SESCs transduced with PAX6(3-D PAX6+ SESCs) upon 3-D differentiation 1.12
Ribosomal protein RPL26 is the principal target of UFMylation 1.09
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 1.06
The transcriptomic differences between Th1, Tr1, and Tneg cells in controlled human malaria infection 1.06
Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing 1.04
Inhibition of H3K4 demethylation induces autophagy in cancer cell lines 1.03
Aberrant expression profile of lncRNA and mRNA in dilated cardiomyopathy by RNA-sequence 1.02
Gene expression profiles of PD1-high, PD1-intermediate, and PD1-negative tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.99
Temporal comparison of transcriptomic alterations in human, mouse and rat primary B lymphocytes exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) 0.99
The mithralog EC-7072 is highly cytotoxic to chronic lymphocytic leukemia cells by targeting the B-cell receptor signaling pathway 0.98
Generation and persistence of human tissue-resident memory T cells in lung transplantation 0.97
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer 0.97
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer [RNA-Seq] 0.97
Urinary sediment transcriptomic and longitudinal data to investigate renal function decline in type 1 diabetes 0.94
Kidney compartment specific eQTL studies highlight causal genes and pathways for renal disease development 0.93
Transcriptome analysis of Riociguat and Vehicle control treatment in human hematopoietic stem and progenitor cells 0.93
Gene expression analysis of human hepatocellular cancers 0.91
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 0.9
Targeting EZH2 in MYCN-amplified Neuroblastoma 0.88
Targeting EZH2 in MYCN-amplified Neuroblastoma [RNA-seq] 0.88
Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogels [RNA-Seq] 0.88
Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogels 0.88
Expression profile of MM.1S tumors folloiwing treatment with bortezomib 0.86
Myc activation coordinates gene transcription and protein translation responses 0.85
single cell RNA-seq from GM12878 (ENCSR673UIY) 0.85
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies 0.81
Determining mRNA half-lives on a transcriptome-wide scale 0.72
Trans-differentiation of human adult peripheral blood T cells into neurons 0.71
IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis 0.7
UMI-count modeling and differential expression analysis for single-cell RNA sequencing 0.7
Loss of EGFR-DDEF1 signaling in metastatic and unresectable hepatoblastoma 0.68
Antiviral and anti-inflammatory properties of novel anti-HIV candidate ABX464 promotes specifics RNA splicing while preserving cellular RNA integrity. 0.67
Programmable RNA N6-methyladenosine editing by CRISPR-Cas9 conjugates 0.66
The control of rRNA synthesis during the directed differentiation of human embryonic stem cells precedes heterochromatin formation. 0.65
The effect of slow and rapid H2S production on the levels of LPS-induced proinflammatory mediators and transcription in different human cell cultures 0.64
In search for materials able to be colonized by a normal endothelium: сharacterization and NGS gene expression profiling of human primary endotheliocytes cultivated on electrospun 3D matrices 0.63
Transcriptomic Analysis of Endothelial Cells from Fibrovascular Membranes in Proliferative Diabetic Retinopathy 0.63
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [SLAM-Seq] 0.6
Transcriptome sequencing identify a recurrent CRYL1-IFT88 chimeric transcript in hepatocellular carcinoma 0.58
Diarrhoeal mechanisms of the Campylobacter jejuni enteritis 0.57
Transcriptome analysis of the HepG2 cells expressing hepatic transcription factors 0.57
RNA-seq analysis of SLIRP knockdown with 1nM DHT in LNCaP cells 0.55
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 0.55
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 0.55
Transcriptome analysis of fetal Klinefelter testis tissue samples compared to controls 0.54
Gene expression activation in CLL mediated by MSCs contact 0.53
A High-Throughput Screen Identifies DYRK inhibitor ID-8 that Stimulates Human Kidney Tubular Proliferation 0.52
Next Generation Sequencing for Quantitative Analysis of transcriptome of follicular compared to non-follicular CD8 T cells from HIV+ Lymph nodes 0.52
Metabolism as an early predictor of DPSCs aging 0.5
Transcriptome-wide modulation of splicing by the exon junction complex 0.46
Human pulmonary artery endothelial cells (hPAECs) with downregulated BMPR2 signaling demonstrate a unique gene expression signature after exposure to overexpression of AdAlox5 0.45
Organelle-based therapy for immune mediated disease: mitochondrial transfer elicits Tregs reprogramming 0.43
Metastasis in triple-negative breast cancer 0.43
Functional and genomic characterization of a xenograft model system for the study of metastasis in triple-negative breast cancer. 0.43
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 0.43
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 0.43
Comparative gene expression profiling of human primary endotheliocytes cultivated on polyurethane-based electrospun 3D matrices and natural decellularized vein 0.38
Longitudinal transcriptome profiling of post-treatment Lyme disease syndrome 0.33
The flightless I protein is involved in the genome-wide mRNA post-transcriptional regulation in lung carcinoma cells 0.32
RNA-seq of primary patient AML samples 0.31
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 0.29
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 0.29
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 0.27
Transcriptional repression in hypoxia is mediated by the Sin3A histone deacetylase complex [RNA-seq] 0.26
Genome-wide profiling of cervical RNA-binding proteins identified HPV regulation of RNASEH2A expression by viral E7 and E2F1 0.26
Gene expression profile of human multiple myeloma cell line MM.1S after knockdown of KDM6B 0.24
High-resolution comparative analysis of great ape genomes 0.24
Agonistic targeting of TLR1/TLR2 induces p38 MAPK-dependent apoptosis and NfkB-dependent differentiation of AML cells 0.23
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 0.22
Effect of hyper-and hypoactivation of Notch signaling in IL-4-stimulate THP-1 0.22
The role of the Calcium-Sensing receptor in colorectal cancer 0.21
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells 0.21
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 0.21
RNA-seq of IL-4 stimulated human keratinocytes 0.17
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 0.16
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  0.16
RNA-seq data 0.15
MicroRNA Marker Based Prognostication of Oral Squamous Cell Carcinoma 0.15
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors 0.14
The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and converts them into tumorigenic cells 0.14
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 0.14
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 0.12
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses 0.11
Peripheral whole blood mRNAs and lncRNAs expression analysis in eosinophilic asthmatics 0.11
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HCT116 cells treated with or without TNF-alpha 0.11
Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) regulates metabolic adaptation and glucose-independent tumor cell growth 0.08
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] 0.07
Induction of extracellular adenosine salvage and metabolic quiescence regulate the transitional to follicular B cell checkpoint in humans. 0.06
Wnt1 silences CC/CXC motif chemokine genes in dendritic cells and induces adaptive immune resistance in lung adenocarcinoma 0.03
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 0.02


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation